Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Surgisphere was a healthcare data analytics company that claimed to provide a massive, real-time database of electronic health records from hospitals worldwide. The company rose to prominence during the COVID-19 pandemic when its data was used in influential studies published in The Lancet and the New England Journal of Medicine regarding hydroxychloroquine and cardiovascular health. These studies were retracted after independent auditors were unable to verify the raw data, sparking a major scandal in the scientific community. The company's primary product was the QuartzClinical platform, which was marketed as a machine learning tool for hospital efficiency. Following the retractions, Surgisphere's operations ceased and its online presence was removed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Surgisphere.